73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study confirms disparities in triple-negative breast cancer diagnoses

Study confirms disparities in triple-negative breast cancer diagnoses

by WileyCredit: CC0 Public DomainA new study published early online inCancer, a peer-reviewed journal of the American Cancer Society, shows that women of color and young women may face elev

Study confirms disparities in triple-negative breast cancer diagnoses

by WileyCredit: CC0 Public DomainA new study published early online inCancer, a peer-reviewed journal of the American Cancer Society, shows that women of color and young women may face elev
Exercise may help reduce long-term side effects of chemotherapy for breast cancer patients

Exercise may help reduce long-term side effects of chemotherapy for breast cancer patients

by University of AmsterdamCredit: CC0 Public DomainAfter treatment for breast cancer, most women suffer side effects such as fatigue, not feeling physically fit and cognitive issues. This can oft

Exercise may help reduce long-term side effects of chemotherapy for breast cancer patients

by University of AmsterdamCredit: CC0 Public DomainAfter treatment for breast cancer, most women suffer side effects such as fatigue, not feeling physically fit and cognitive issues. This can oft
One million children lose mother to cancer a year: research

One million children lose mother to cancer a year: research

Credit: Pixabay/CC0 Public DomainAround one million children worldwide lose their mother to cancer every year, often leaving orphans caught up in a "vicious cycle of disadvantage", researche

One million children lose mother to cancer a year: research

Credit: Pixabay/CC0 Public DomainAround one million children worldwide lose their mother to cancer every year, often leaving orphans caught up in a "vicious cycle of disadvantage", researche
Here's what you can eat and avoid to reduce your risk of bowel cancer

Here's what you can eat and avoid to reduce your risk of bowel cancer

by Suzanne Mahady,The ConversationCredit: ready made from PexelsAustralia has one of thehighest rates of bowel cancer in the world. In 2017, bowel cancer was thesecond most common ca

Here's what you can eat and avoid to reduce your risk of bowel cancer

by Suzanne Mahady,The ConversationCredit: ready made from PexelsAustralia has one of thehighest rates of bowel cancer in the world. In 2017, bowel cancer was thesecond most common ca
Drug mechanism opens door for new anti-cancer immunotherapies

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun
1999 to 2018 saw increase in cancer survivors with functional limitation, finds research

1999 to 2018 saw increase in cancer survivors with functional limitation, finds research

by Elana GotkineFrom 1999 to 2018, there was a more than twofold increase in the number of cancer survivors reporting functional limitations, according to a research letter published online May 11 in&

1999 to 2018 saw increase in cancer survivors with functional limitation, finds research

by Elana GotkineFrom 1999 to 2018, there was a more than twofold increase in the number of cancer survivors reporting functional limitations, according to a research letter published online May 11 in&
FDA Approves Two Cell-Based SCD Gene Therapies

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient
Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi

Study finds behavior matters far more to lifetime exposure to cancer-causing radiation than previously believed

by Allie Miller,University of CalgaryResidential radon exposure periods modified by radon awareness behavior and test decision-making that can differ by age, sex/gender or parental status. Credi
Researchers describe a new method to test cancer drug toxicity

Researchers describe a new method to test cancer drug toxicity

by Tufts UniversityCredit: Pixabay/CC0 Public DomainFor people with cancer, chemotherapy saves lives, but for some patients, the treatment comes with a side effect—heart damage. Screening cancer

Researchers describe a new method to test cancer drug toxicity

by Tufts UniversityCredit: Pixabay/CC0 Public DomainFor people with cancer, chemotherapy saves lives, but for some patients, the treatment comes with a side effect—heart damage. Screening cancer
Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b
Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel
Researchers find simpler, more effective cancer vaccine approach

Researchers find simpler, more effective cancer vaccine approach

by Sarah Avery,Duke UniversityGraphical abstract. Credit: American Society for Clinical InvestigationUsing a precursor to dendritic cells appears to be an efficient and effective way to stimulat

Researchers find simpler, more effective cancer vaccine approach

by Sarah Avery,Duke UniversityGraphical abstract. Credit: American Society for Clinical InvestigationUsing a precursor to dendritic cells appears to be an efficient and effective way to stimulat